Statements (13)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:physicist
|
| gptkbp:bfsLayer |
5
|
| gptkbp:bfsParent |
gptkb:Fabrazyme
|
| gptkbp:activities |
gptkb:physicist
|
| gptkbp:appointed_by |
intravenous infusion
|
| gptkbp:approves |
gptkb:FDA
|
| gptkbp:brand |
gptkb:Fabrazyme
|
| https://www.w3.org/2000/01/rdf-schema#label |
agalsidase beta
|
| gptkbp:ingredients |
C_20 H_30 N_4 O_6 S
|
| gptkbp:is_used_for |
gptkb:Fabry_disease
|
| gptkbp:produced_by |
recombinant DNA technology
|
| gptkbp:side_effect |
infusion reactions
|
| gptkbp:targets |
lysosomal storage disorder
|